Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 23010279 | MHC (MHC) | sporadic inclusion body myositis | Australian | NA | NA | unclassified | |
| analysis of hla-drb3 alleles and supertypical genotypes in the mhc class ii region in sporadic inclusion body myositis. | |||||||
| 25065005 | HLA-DR3 (BROAD ANTIGEN) | sporadic inclusion body myositis | French | NA | NA | unclassified | |
| the prevalence of sporadic inclusion body myositis (sibm) was correlated with the frequency of hla-dr3. | |||||||
| 29611059 | HLA-DRB1*03 | sporadic inclusion body myositis | NA | NA | NA | unclassified | |
| purpose of reviewour goal is to review the recent literature pertaining to the genetics of sporadic inclusion body myositis (ibm).recent findingsin a study of 252 ibm patients, the class ii mhc allele hla-drb1*03:01 showed the most significant association with ibm, and that risk could be largely attributed to amino acids within the peptide-binding pocket. | |||||||
| 9644643 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | thrombophilia | NA | NA | NA | unclassified | |
| the distribution of classic risk factors associated with acute rejections, such as number of human leukocyte antigen mismatches or percentage of panel-reactive antibodies, was similar in patients with and without thrombophilia. | |||||||
| 10522894 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | thrombophilia | Asian | NA | NA | unclassified | |
| both had cerebral angiography, mri, magnetic resonance angiography, spect, eeg, human leukocyte antigen (hla) typing, evaluation of thrombophilia, and immunologic and karyotype analysis. | |||||||
| 25389083 | HLA (HLA) | thrombophilia | NA | prednisolone | NA | unclassified | |
| antibody-mediated rejection (abmr) occurred in one patient with thrombophilia and low level donor-specific anti-hla antibody. | |||||||
| 9646098 | HLA-CLASS II (HLA CLASS II) | atherogenesis | NA | NA | NA | unclassified | |
| the co-localization of cd4+ t-cells and macrophages in the lesion, the abundant expression of hla class ii molecules and the co-stimulatory molecule cd40 and its ligand (cd40l) indicate a contribution of cell-mediated immunity to atherogenesis. | |||||||
| 9664754 | NA (NA) | migraine with aura | NA | NA | NA | unclassified | |
| igg antibodies against non-hla class i platelet antigens were found in 9.5% of patients with migraine without aura, 7.6% of patients with migraine with aura, and in 7.5% of controls; igm antibodies were found in 11.9% of patients with migraine without aura, in 30.8% of patients with migraine with aura, and in 13.1% of controls. | |||||||
| 9664754 | NA (NA) | migraine without aura | NA | NA | NA | unclassified | |
| igg antibodies against non-hla class i platelet antigens were found in 9.5% of patients with migraine without aura, 7.6% of patients with migraine with aura, and in 7.5% of controls; igm antibodies were found in 11.9% of patients with migraine without aura, in 30.8% of patients with migraine with aura, and in 13.1% of controls. | |||||||
| 9952029 | HLA-DR2 (BROAD ANTIGEN) | migraine with aura | NA | NA | NA | unclassified | |
| chromosome 6p-encoded hla-dr2 determination discriminates migraine without aura from migraine with aura. | |||||||
Copyright 2024